Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine in Adolescents with ADHD and Substance Use Disorders
NCT00029614Phase 2Completed
- Sponsor
- University of Pittsburgh
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atomoxetine in attention deficit hyperactivity disorder (ADHD), alcohol use disorder (AUD), substance use disorder (SUD), sponsored by University of Pittsburgh. Started May 2006; status: completed.
02
Drugs
atomoxetine
03
Conditions
attention deficit hyperactivity disorder (ADHD)alcohol use disorder (AUD)substance use disorder (SUD)
Beyond the preview
Go deeper on NCT00029614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00029614.